PlainPharmaWatch

CMS Open Payments · Tool

Acist Medical Systems, Inc. vs Lumendi LLC

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Lumendi LLC has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 2,475, versus 931 for the other company. Its single largest recorded recipient represents 34.7% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Acist Medical Systems, Inc.
HHI 931 · top recipient 22.6%
Ranked #1,055 of 1,838 companies by HHI
Lumendi LLC
HHI 2,475 · top recipient 34.7%
Ranked #657 of 1,838 companies by HHI

Payment Overview

Total Payments
$163.3K
% of Industry
0.0%
Transactions
644
Avg per Transaction
$253.51
Recipients
644
Avg per Recipient
$253.51
Payment Types
4
Top Payment Type
Consulting Fee
Company B

Lumendi LLC

Total Payments
$164.6K
% of Industry
0.0%
Transactions
83
Avg per Transaction
$2.0K
Recipients
83
Avg per Recipient
$2.0K
Payment Types
5
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Acist Medical Systems, Inc. vs Lumendi LLC - total reported payments in CMS Open Payments PY2024

Lumendi LLC$164.6KAcist Medical Systems, Inc.$163.3K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Acist Medical Systems, Inc.

Consulting Fee $112.7K

69.0%

Food and Beverage $29.4K

18.0%

Space Rental or Facility Fees $20.0K

12.3%

Travel and Lodging $1.1K

0.7%

Lumendi LLC

Consulting Fee $138.4K

84.1%

Travel and Lodging $11.0K

6.7%

Compensation for Services Other Than Consulting $7.3K

4.4%

Space Rental or Facility Fees $6.0K

3.6%

Food and Beverage $1.9K

1.1%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Acist Medical Systems, Inc.

  1. 1

    THOMAS BIGGS

    $36,850.59 · 11 txns

  2. 2

    Washington Hospital Center

    $20,000.00 · 1 txns

  3. 3

    MICHAEL J. DAVIS

    $15,450.00 · 6 txns

  4. 4

    MICHAEL A. DAVIS

    $12,000.00 · 5 txns

  5. 5

    JEFFREY WILSON

    $10,446.10 · 9 txns

Lumendi LLC

  1. 1

    SERGEY KANTSEVOY

    $57,077.62 · 14 txns

  2. 2

    IHYA E GORGUN

    $56,395.50 · 13 txns

  3. 3

    MOLHAM ABDULSAMAD

    $8,186.09 · 5 txns

  4. 4

    Adventhealth Orlando

    $6,000.00 · 1 txns

  5. 5

    OVUNC BARDAKCIOGLU

    $5,812.31 · 4 txns

Summary Comparison

Metric Acist Medical Systems, Inc. Lumendi LLC
Total Payments $163.3K $164.6K
% of Industry Total 0.0% 0.0%
Transaction Count 644 83
Avg per Transaction $253.51 $2.0K
Recipient Count 644 83
Avg per Recipient $253.51 $2.0K
Payment Type Count 4 5
Top Payment Type Consulting Fee Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.